Ribozyme gene therapy: applications for molecular medicine (Q34234190)

31 July 2017

1 reference

title

Ribozyme gene therapy: applications for molecular medicine (English)

1 reference

31 July 2017

0 references

0 references

Lewin AS

1

1 reference

31 July 2017

Hauswirth WW

series ordinal

2

1 reference

31 July 2017

publication date

1 May 2001

1 reference

Trends in Molecular Medicine

31 July 2017

published in

1 reference

31 July 2017

volume

7

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

221-228

1 reference

Isolation of new ribozymes from a large pool of random sequences [see comment]

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

In Vitro Selection of Catalytic Polynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

A general purpose RNA-cleaving DNA enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

A general two-metal-ion mechanism for catalytic RNA

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

The effect of structure in a long target RNA on ribozyme cleavage efficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Synthesis of 2'-modified nucleotides and their incorporation into hammerhead ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Pharmacokinetics and tissue distribution of a ribozyme directed against hepatitis C virus RNA following subcutaneous or intravenous administration in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Improved cationic lipid formulations for in vivo gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Immune responses to adenovirus and adeno-associated virus in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Latent adeno-associated virus infection elicits humoral but not cell-mediated immune responses in a nonhuman primate model

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Expression of small, therapeutic RNAs in human cell nuclei.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Factors governing the activity in vivo of ribozymes transcribed by RNA polymerase III.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Recent advances in inducible gene expression systems

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

mRNA localization signals can enhance the intracellular effectiveness of hammerhead ribozymes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Ribozyme as an approach for growth suppression of human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

A novel allosterically trans-activated ribozyme, the maxizyme, with exceptional specificity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Therapeutic efficacy of an adenovirus-mediated anti-H-ras ribozyme in experimental bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Acute toxicology and pharmacokinetic assessment of a ribozyme (ANGIOZYME) targeting vascular endothelial growth factor receptor mRNA in the cynomolgus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Pharmacokinetics of an antiangiogenic ribozyme (ANGIOZYME) in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Ribozyme therapy for HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Resistance to human immunodeficiency virus type 1 infection conferred by transduction of human peripheral blood lymphocytes with ribozyme, antisense, or polymeric trans-activation response element constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Preclinical characterization of an anti-tat ribozyme for therapeutic application

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

A marker study of therapeutically transduced CD4+ peripheral blood lymphocytes in HIV discordant identical twins

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Aggregation and Motor Neuron Toxicity of an ALS-Linked SOD1 Mutant Independent from Wild-Type SOD1

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Hammerhead ribozymes selectively suppress mutant type I collagen mRNA in osteogenesis imperfecta fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Ribozyme rescue of photoreceptor cells in P23H transgenic rats: long-term survival and late-stage therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Strategems in vitro for gene therapies directed to dominant mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Ribozyme-mediated repair of defective mRNA by targeted, trans-splicing

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Evaluating group I intron catalytic efficiency in mammalian cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Trans -splicing ribozymes for targeted gene delivery 1 1Edited by J. Karn

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Efficient integration of an intron RNA into double-stranded DNA by reverse splicing

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Group II introns designed to insert into therapeutically relevant DNA target sites in human cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

RNase P in research and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Requirements for cleavage by a modified RNase P of a small model substrate

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Inactivation of gene expression using ribonuclease P and external guide sequences.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Spliceosome-mediated RNA trans-splicing as a tool for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Collagen 17A1 gene correction using spliceosome mediated RNA trans-splicing (SMaRTtrade mark) technology

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Human gene targeting by viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

In vivo site-directed mutagenesis of the factor IX gene by chimeric RNA/DNA oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Gene correction in hematopoietic progenitor cells by homologous recombination

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

Expression of ribozymes in gene transfer systems to modulate target RNA levels

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2801%2901965-7

7 January 2021

10.1016/S1471-4914(01)01965-7

Identifiers

DOI

1 reference

31 July 2017

1 reference